Filing Details
- Accession Number:
- 0001209191-14-034854
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-19 09:28:08
- Reporting Period:
- 2014-05-16
- Filing Date:
- 2014-05-19
- Accepted Time:
- 2014-05-19 09:28:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 786947 | Acura Pharmaceuticals Inc | ACUR | Pharmaceutical Preparations (2834) | 110853640 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1107934 | F James Emigh | C/O Acura Pharmacuticals, Inc. 616 N. North Court, Suite 120 Palatine IL 60067 | Vp Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-16 | 15,000 | $1.21 | 198,304 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
